Thrapeutic equivalence in the treatment of hypertension: Can lercanidipine and nifedipine GITS be considered to be interchangeable?

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 6

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Cardiol. Jun 26, 2014; 6(6): 507-513
Published online Jun 26, 2014. doi: 10.4330/wjc.v6.i6.507

Full Size Figure Download Figure

Figure 3 Dose and time-dependency of the development of peripheral oedema. Adapted from the second meta-analysis[7].

Citation: Elliott HL, Meredith PA. Thrapeutic equivalence in the treatment of hypertension: Can lercanidipine and nifedipine GITS be considered to be interchangeable? World J Cardiol 2014; 6(6): 507-513
URL: https://www.wjgnet.com/1949-8462/full/v6/i6/507.htm
DOI: https://dx.doi.org/10.4330/wjc.v6.i6.507

Elliott HL, Meredith PA. Thrapeutic equivalence in the treatment of hypertension: Can lercanidipine and nifedipine GITS be considered to be interchangeable? World J Cardiol 2014; 6(6): 507-513 [PMID: 24976923 DOI: 10.4330/wjc.v6.i6.507]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.